Serotonergic loss in motor circuitries correlates with severity of action-postural tremor in PD

Neurology

Volumn 80, Issue 20, 2013, Pages 1850-1855

  Loane, Clare ^a   Wu, Kit ^a   Bain, Peter ^a   David, J ^a   Piccini, Paola ^a   Politis, Marios ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DASB C 11; RADIOPHARMACEUTICAL AGENT; SEROTONIN; SEROTONIN TRANSPORTER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; MALE; PARKINSON DISEASE; PET SCANNER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM; TREMOR;

AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; MOTOR CORTEX; NERVE NET; PARKINSON DISEASE; POSITRON-EMISSION TOMOGRAPHY; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEVERITY OF ILLNESS INDEX; TREMOR;

EID: 84879112972     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e318292a31d     Document Type: Article

References (26)

1. Rajput A. Clinical features of tremor in extrapyramidal syndromes. In: Findley LJ, Koller WC, editors. Handbook of Tremor Disorders. New York: Marcel Dekker; 1995:275-291.
2. Kish SJ, Tong J, Hornykiewicz O, et al. Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease. Brain 2008;131; 120-131.
3. Politis M, Wu K, Loane C, et al. Staging of serotonergic dysfunction in Parkinson's disease: an in vivo 11C-DASB PET study. Neurobiol Dis 2010;40:216-221.
4. Politis M, Loane C, Wu K, Brooks DJ, Piccini P. Serotonergic mediated body mass index changes in Parkinson's disease. Neurobiol Dis 2010;43:609-615.
5. Politis M, Wu K, Loane C, et al. Depressive symptoms in PD correlate with higher 5-HTT binding in raphe and limbic structures. Neurology 2010;75:1920-1927.
6. Koller WC, Hubble JP. Levodopa therapy in Parkinson's disease. Neurology 1990;40:40-47.
7. Brooks DJ, Playford ED, Ibanez V, et al. Isolated tremor and disruption of the nigrostriatal dopaminergic system: an 18F-dopa PET study. Neurology 1992;42:1554-1560.
8. Pavese N, Evans AH, Tai YF, et al. Clinical correlates of levodopa-induced dopamine release in Parkinson disease: a PET study. Neurology 2006;67:1612-1617.
9. Coppen A, Metcalfe M, Carroll JD, Morris JG. Levodopa and L-tryptophan therapy in Parkinsonism. Lancet 1972;1:654-658.
10. Hildebrand J, Delecluse F. Effect of ritanserin, a selective serotonin-S2 antagonist, on Parkinson's rest tremor. Curr Ther Res 1987;41:298-300.
11. Ginovart N, Willeit M, Rusjan P, et al. Positron emission tomography quantification of [11C]-(1)-PHNO binding in the human brain. J Cereb Blood Flow Metab 2007;27:857-871.
12. Ichise M, Liow JS, Lu JQ, et al. Linearized reference tissue parametric imaging methods: application to [11C]DASB positron emission tomography studies of the serotonin transporter in human brain. J Cereb Blood Flow Metab 2003;23:1096-1112.
13. Brix G, Zaers J, Adam LE, et al. Performance evaluation of a whole-body PET scanner using the NEMA protocol. National Electrical Manufacturers Association. J Nucl Med 1997;38:1614-1623.
14. Montgomery AJ, Thielemans K, Mehta MA, Turkheimer F, Mustafovic S, Grasby PM. Correction of head movement on PET studies: comparison of methods. J Nucl Med 2006;47:1936-1944.
15. Innis RB, Cunningham VJ, Delforge J, et al. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab 2007;27:1533-1539.
16. Logan J, Fowler JS, Volkow ND, Wang GJ, Ding YS, Alexoff DL. Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab 1996;16:834-840.
17. Kish SJ, Furukawa Y, Chang LJ, et al. Regional distribution of serotonin transporter protein in postmortem human brain: is the cerebellum a SERT-free brain region? Nucl Med Biol 2005;32:123-128.
18. Doder M, Rabiner EA, Turjanski N, Lees AJ, Brooks DJ. Tremor in Parkinson's disease and serotonergic dysfunction: an 11C-WAY 100635 PET study. Neurology 2003;60:601-605.
19. van der Kooy D, Hattori T. Dorsal raphe cells with collateral projections to the caudate-putamen and substantia nigra: a fluorescent retrograde double labeling study in the rat. Brain Res 1980;186:1-7.
20. Jellinger K. Overview of morphological changes in Parkinson's disease. Adv Neurol 1987;45:1-18.
21. Halliday GM, Blumbergs PC, Cotton RGH, Blessing WW, Geffen LB. Loss of brain stem serotonin-and substance P-containing neurons in Parkinson's disease. Brain Res 1990;510:104-107.
22. Lalley PM. Analysis of Pharmacologically-activated Tremor Mechanisms in the Caudate Nucleus. Ann Arbor, MI: Univsity Microfilms; 1971.
23. Isaias IU, Marotta G, Hirano S, et al. Imaging essential tremor. Mov Disord 2010;6:679-686.
24. Kim SJ. Delayed onset hand tremor caused by cerebral infarction. Stroke 1992;23:292-294.
25. Grimes JD, Hassan MN, Quarrington AM, et al. Delayed onset posthemiplegic dystonia: CT demonstration of basal ganglia pathology. Neurology 1982;32:1033-1035.
26. Dethy S, Luxen A, Bidaut LM, et al. Hemibody tremor related to stroke. Stroke 1993;24:2064-2096.